Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1

Circulation

Volumn 107, Issue 10, 2003, Pages 1411-1417

  Tomita, Naruya ^a   Morishita, Ryuichi ^a,b   Taniyama, Yoshiaki ^a   Koike, Hiromi ^b   Aoki, Motokuni ^a   Shimizu, Hideo ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Kaneda, Yasufumi ^b   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Cells; Growth substances; Metalloproteinases

Indexed keywords

INTERSTITIAL COLLAGENASE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0037453059     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000055331.41937.AA     Document Type: Article

References (35)

1. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998; 97:1114-1123.
2. Isner JM, Baumgartner I, Rauh G, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg. 1998; 28:964-973.
3. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998; 98:2800-2804.
4. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999;100:468-474.
5. Nakamura Y, Morishita R, Higaki J, et al. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens. 1996;14:1067-1072.
6. Nakamura Y, Morishita R, Higaki J, et al. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun. 1995;215:483-488.
7. Belle EV, Witzenbichler B, Chen D, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation. 1998;97:381-390.
8. Hayashi S, Morishita R, Nakamura S, et al. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: down-regulation of HGF in response to hypoxia in vascular cells. Circulation. 1999;100(suppl II):II-301-II-308.
9. Taniyama Y, Morishita R, Aoki M, et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001;8:181-189.
10. Taniyama Y, Morishita R, Hiraoka K, et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation. 2001;104:2344-2350.
11. Aoki M, Morishita R, Taniyama Y, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther. 2000;7:417-427.
12. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11: 73-91.
13. Iwasaka C, Tanaka K, Abe M, et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol. 1996;169:522-531.
14. Wasylyk C, Kerckaert JP, Wasylyk B. A novel modulator domain of Ets transcription factors. Genes Dev. 1992;6:965-974.
15. Kola I, Brookes S, Green AR, et al. The Ets 1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA. 1993;90:7588-7592.
16. Vandenbunder B, Wernert N, Queva C, et al. Does the transcription factor c-etsl take part in the regulation of angiogenesis and tumor invasion? Folia Biol Praha. 1994;40:301-313.
17. Nerlov C, Rorth P, Blasi F, et al. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene. 1991;6:1583-1592.
18. Gum R, Lengyel E, Juarez J, et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem. 1996;271:10672-10680.
19. Tomita N, Morishita R, Tomita S, et al. Inhibition of TNF-alpha induced cytokine and adhesion molecule expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB. Exp Nephrol. 2001;9:181-190.
20. Morishita R, Gibbons GH, Kaneda Y, et al. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the vessel wall: enhanced therapeutic utility for restenosis by HVJ-liposome method. Gene. 1994; 149:13-19.
21. Liu Y, Michalopoulos GK, Zarnegar R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem. 1994;269:4152-4160.
22. Gambarotta G, Boccaccio C, Giordano S, et al. Ets up-regulates MET transcription. Oncogene. 1996;13:1911-1917.
23. Witzenbichler B, Kureishi Y, Luo Z, et al. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J Clin Invest. 1999;104:1469-1480.
24. Naito S, Shimizu S, Nakashima M, et al. Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cels. Biochem Biophys Res Commun. 2001;291: 130-138.
25. Ozaki I, Zhao G, Mizuta T, et al. Hepatocyte growth factor induces collagenase. J Hepatol. 2002;36:169-178.
26. Hayashi S, Morishita R, Higaki J, et al. Autocrine-paracrine effects of over-expression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun. 1996;220:539-545.
27. Ono K, Matsumori A, Shioi T, et al. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation. 1997;95:2552-2558.
28. Kappel A, Schlaeger TM, Flamme I, et al. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood. 2000;96: 3078-3085.
29. Wojta J, Kaun C, Breuss JM, et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab Invest. 1999;79:427-438.
30. Wakiya K, Begue A, Stehelin D, et al. cAMP response element and an ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J Biol Chem. 1996; 271:30823-30828.
31. Valter MM, Hugel A, Huang HJ, et al. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res. 1999;59:5608-5614.
32. Oka T, Rairkar A, Chen JH. Structural and functional analysis of the regulatory sequences of the ets-1 gene. Oncogene. 1991;11:2077-2083.
33. Seth A, Papas TS. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene. 1990;12:1761-1767.
34. Nakano T, Abe M, Tanaka K, et al. Angiogenesis inhibition by transdominant mutant Ets-1. J Cell Physiol. 2000;184:255-262.
35. Teruyama K, Abe M, Nakano T, et al. Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells. J Cell Physiol. 2001;188:243-252.